Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

15 Apr 2024 07:00

RNS Number : 5115K
Chesnara PLC
15 April 2024
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

15th April 2024

 

CHESNARA plc

("Chesnara" or "the Company")

 

CHESNARA PLC CHANGE OF DIRECTORSHIP

 

 

On 7th December 2023, Chesnara (CSN.L) announced that David Rimmington would step down as Group Finance Director and as a Director of Chesnara at the conclusion of the 2024 Annual General Meeting ("AGM") and that Tom Howard would be appointed Group Chief Financial Officer ("Group CFO") at that time subject to regulatory approval.

 

Tom Howard has today been appointed an Executive Director of Chesnara and, with his regulatory approval already secured, will become Chesnara's Group CFO upon election at the 14th May AGM. The 2023 Directors' Remuneration Report, to be published on Wednesday 17th April 2024, will set out information on Tom's remuneration.

 

 

 

 

Name of authorised official of issuer responsible for making notification: - Amanda Wright

 

Date of notification: - 15th April 2024

 

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden, the Netherlands and the UK and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 19 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAITMFTMTBBBBI
Date   Source Headline
13th May 20251:00 pmRNSSenior Independent Director Appointment
13th May 202512:44 pmRNSAGM Statement
1st May 20257:00 amRNSTotal Voting Rights
25th Apr 20257:00 amRNSBlock listing Interim Review
24th Apr 20257:00 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSNotice of AGM
7th Apr 202512:30 pmRNSApplication for Block Listing - Replacement
7th Apr 202512:09 pmRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSApplication for Block Listing
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20252:45 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
10th Mar 20251:41 pmRNSNotice of Results (Replacement)
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20259:07 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirectorate Changes
23rd Dec 20247:00 amRNSAcquisition
12th Dec 202412:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:55 pmRNSDirector/PDMR Shareholding
14th Nov 20242:06 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSBlock listing Interim Review
11th Sep 20247:00 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSHalf-year Report
12th Aug 20249:00 amRNSNotice of Half Year Results
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
18th Jul 20249:00 amRNSExternal Directorship
10th Jul 20249:00 amRNSHolding(s) in Company
7th Jun 202411:28 amRNSDirector/PDMR Shareholding
6th Jun 20243:30 pmEQSHardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A
16th May 20247:00 amRNSDirector/PDMR Shareholding
14th May 20242:15 pmRNSAGM Statement
9th May 20242:04 pmEQSQ&A on Chesnara plc (CSN): Growth and stability insights
30th Apr 20244:45 pmRNSDirector/PDMR Shareholding
26th Apr 20244:57 pmRNSDirector/PDMR Shareholding
25th Apr 202410:00 amRNSBlock listing Interim Review
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSDirectorate Change
11th Apr 202410:23 amEQSHardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress
9th Apr 20244:58 pmRNSDirectorate Change
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
3rd Apr 20241:33 pmRNSDirector/PDMR Shareholding
28th Mar 202412:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSFinal Results
21st Mar 20247:45 amRNSDirector Declaration
14th Mar 202411:15 amRNSNotice of Results
29th Dec 202311:55 amRNSTotal Voting Rights
29th Dec 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.